Landos Biopharma, Inc. 4 SEC Filings

Filed On	Filing
23 May 2024	Form 4: Mayleben Timothy M, Director Disposed of 3,600 Stock Option (right to buy) (Disposition to Issuer)
23 May 2024	Form 4: Girao Tiago, Director Disposed of 5,400 Stock Option (right to buy) (Disposition to Issuer)
23 May 2024	Form 4: Callori Fred, Director Disposed of 5,400 Stock Option (right to buy) (Disposition to Issuer)
23 May 2024	Form 4: Batycky Alka, Director Disposed of 3,600 Stock Option (right to buy) (Disposition to Issuer)
23 May 2024	Form 4: Adsett Roger, Director Disposed of 7,200 Stock Option (right to buy) (Disposition to Issuer)
23 May 2024	Form 4: Garabedian Christopher Nishan, Director Disposed of 5,400 Stock Option (right to buy) (Disposition to Issuer)
23 May 2024	Form 4: Cataldi Fabio, Chief Medical Officer Disposed of 48,813 Restricted Stock Unit (Disposition to Issuer) · Disposed of 58,448 Employee Stock Option (right to buy) (Disposition to Issuer)
23 May 2024	Form 4: Oakes Gregory, Director Disposed of 54,454 Restricted Stock Unit (Disposition to Issuer) · Disposed of 215,253 Employee Stock Option (right to buy) (Disposition to Issuer)
04 Mar 2024	Form 4: Cataldi Fabio, Chief Medical Officer Granted 21,138 Restricted Stock Unit
04 Mar 2024	Form 4: Oakes Gregory, Director Granted 54,454 Restricted Stock Unit
01 Jun 2023	Form 4: Batycky Alka, Director Granted 3,600 Stock Option (right to buy)
24 May 2023	Form 4: Mayleben Timothy M, Director Granted 18,000 Stock Option (right to buy)
24 May 2023	Form 4: Girao Tiago, Director Granted 18,000 Stock Option (right to buy)
24 May 2023	Form 4: Garabedian Christopher Nishan, Director Granted 18,000 Stock Option (right to buy)
24 May 2023	Form 4: Callori Fred, Director Granted 18,000 Stock Option (right to buy)
24 May 2023	Form 4: Adsett Roger, Director Granted 18,000 Stock Option (right to buy)
02 Mar 2023	Form 4: Bassaganya-Riera Josep, 10% owner Sold 5,720,868 shares
02 Mar 2023	Form 4: Cataldi Fabio, Chief Medical Officer Granted 184,500 Employee Stock Option (right to buy) · Granted 276,750 Restricted Stock Unit
02 Mar 2023	Form 4: Oakes Gregory, Director Granted 475,300 Employee Stock Option (right to buy)
02 Mar 2023	Form 4: Truesdell Patrick, Vice President and Controller Granted 99,600 Employee Stock Option (right to buy) · Granted 99,600 Restricted Stock Unit

Comments